Latest News and Press Releases
Want to stay updated on the latest news?
-
CUMBERLAND, Md., Jan. 21, 2025 (GLOBE NEWSWIRE) -- RS BioTherapeutics, whose mission is to develop life-changing medicines for the millions of people suffering from deadly lung diseases...
-
CUMBERLAND, Md., July 08, 2024 (GLOBE NEWSWIRE) -- RS BioTherapeutics, whose mission is to develop life-changing medicines for the millions of people suffering from deadly lung diseases...
-
RS BioTherapeutics announced today the launch of an SEC Regulation Crowdfunding (Reg CF) investment campaign through StartEngine.
-
RS BioTherapeutics is pleased to announce the addition of Jane Wright-Mitchell, Pharm.D., J.D. to the RS BioTherapeutics Business Advisory Board.
-
RS BioTherapeutics is pleased to announce that its submission has been selected for a poster presentation at the 2024 Respiratory Innovation Summit
-
RS BioTherapeutics is pleased to announce the formation of its Therapeutic Expert Council (TEC).
-
RS BioTherapeutics is pleased to announce that it has appointed Michelle L. Shuffett, MD as its Chief Medical Officer.
-
CUMBERLAND, Md., Aug. 29, 2023 (GLOBE NEWSWIRE) -- RS BioTherapeutics, a life sciences company developing life-changing medicines for the millions of people suffering from diseases characterized by...
-
CUMBERLAND, Md., June 05, 2023 (GLOBE NEWSWIRE) -- RS BioTherapeutics, whose mission is to harness the therapeutic power of cannabinoids in the research, development, and commercialization of life...
-
CUMBERLAND, Md., May 15, 2023 (GLOBE NEWSWIRE) -- RS BioTherapeutics, whose mission is to harness the therapeutic power of cannabinoids in the research, development, and commercialization of life...